CKD Associated With Worse Radical Cystectomy Outcomes
Investigators report increased risks for adverse pathology and 90-day readmission.
Radical Cystectomy
Partial, Radical Cystectomy for MIBC Yield Similar Survival Outcomes
In addition to similar rates of overall survival, patients undergoing partial and radical cystectomy had comparable rates of upstaging to pT3-4 disease.
Survival Odds Similar After Open, Robotic-Assisted Radical Cystectomy
Researchers in The Netherlands compared the surgical approaches in patients with muscle-invasive or high-risk nonmuscle-invasive bladder cancer.
Complete TURBT Before Neoadjuvant Chemotherapy Improves MIBC Outcomes
Complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy in patients scheduled to undergo radical cystectomy for muscle-invasive bladder is associated with improved overall and cancer-specific survival, a study found.
Prophylactic Ureteral Stenting Linked to Upper Tract Urothelial Carcinoma
In current urological practice, clinicians decide whether to place a ureteral stent or nephrostomy, but evidence-based treatment guidance is needed.
Seminal Vesicle-Sparing in Radical Cystectomy Shown to Improve Outcomes
Seminal vesicle-sparing radical cystectomy improved functional results over a median of 64 months without compromising oncologic outcomes, according to investigators.
Study: Routine Surveillance Crucial After Radical Cystectomy
Low adherence to post-radical cystectomy surveillance guidelines may increase patients’ mortality risk, study findings suggest.
Study ID’s Risk Factors for Urethral Recurrence After Radical Cystectomy
Study findings support surveillance for urethral recurrence after radical cystectomy.
Study: Robotic, Open Radical Cystectomy Similarly Effective
Robot-assisted and open radical cystectomy are associated with similar 90-day complication rates, health-related quality of life, and clinical outcomes, according to a recent real-world study.
Bladder Cancer Surgery Safe Following Neoadjuvant Immunotherapy
Toxicity profile and readmission rates among patients who underwent radical cystectomy and pelvic lymph node dissection following neoadjuvant pembrolizumab are in line with previously published series reporting 90-day outcomes after RC with or without neoadjuvant chemotherapy.
- Loading...
Loading...
Next post in Bladder Cancer
Loading... 
Loading...